Effects of nucleoside transport inhibitors and adenine/ribose on ATP concentration and adenosine production in cardiac myocytes.
Kalsi
K K
KK
Heart Science Centre, National Heart and Lung Institute, Harefield Hospital, Harefield, United Kingdom.
Smolenski
R T
RT
Yacoub
M H
MH
D000225:Adenine / Q000031:analogs & derivatives* / Q000494:pharmacology; D000241:Adenosine / Q000378:metabolism*; D058892:Adenosine Deaminase Inhibitors; D000255:Adenosine Triphosphate / Q000378:metabolism*; D000818:Animals; D001692:Biological Transport / Q000187:drug effects; D002478:Cells, Cultured; D004176:Dipyridamole / Q000494:pharmacology*; D006321:Heart / Q000187:drug effects; D009206:Myocardium / Q000378:metabolism*; D051381:Rats; D017207:Rats, Sprague-Dawley; D013868:Thioinosine / Q000031:analogs & derivatives* / Q000494:pharmacology
D058892:Adenosine Deaminase Inhibitors; D013868:Thioinosine; C010192:9-(2-hydroxy-3-nonyl)adenine; D004176:Dipyridamole; D000255:Adenosine Triphosphate; C001789:4-nitrobenzylthioinosine; D000225:Adenine; D000241:Adenosine